Trellus Management Company, LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 95 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trellus Management Company, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$280,670
-13.0%
127,0000.0%0.35%
-8.9%
Q1 2023$322,580
-41.5%
127,000
-56.9%
0.38%
-45.6%
Q4 2022$551,650
-27.2%
295,0000.0%0.70%
-24.1%
Q3 2022$758,000
+33.2%
295,0000.0%0.92%
+32.9%
Q2 2022$569,000
-35.0%
295,0000.0%0.69%
+35.9%
Q1 2022$876,000
-33.9%
295,0000.0%0.51%
-42.2%
Q4 2021$1,325,000
-7.6%
295,0000.0%0.88%
-15.6%
Q3 2021$1,434,000
-26.1%
295,000
+3.7%
1.04%
-22.0%
Q2 2021$1,940,000
-19.2%
284,400
-16.4%
1.34%
+7.8%
Q1 2021$2,400,000
+12.8%
340,0000.0%1.24%
-29.2%
Q4 2020$2,128,000
+31.1%
340,000
+13.3%
1.76%
+5.6%
Q3 2020$1,623,000
+3.6%
300,0000.0%1.66%
-1.9%
Q2 2020$1,566,000
+118.4%
300,000
+31.8%
1.70%
+31.9%
Q1 2020$717,000
+20.9%
227,700
+54.8%
1.29%
+29.5%
Q4 2019$593,000
-25.8%
147,055
-20.5%
0.99%
+24.0%
Q3 2019$799,000
+21.4%
185,000
+12.1%
0.80%
-10.1%
Q2 2019$658,000
+22.8%
165,000
+65.0%
0.89%
-12.7%
Q1 2019$536,000
+46.8%
100,000
+40.4%
1.02%
+23.8%
Q4 2018$365,000
-62.4%
71,200
-28.8%
0.82%
-41.2%
Q3 2018$970,000
-4.9%
100,0000.0%1.40%
-6.7%
Q2 2018$1,020,000
-12.5%
100,000
+11.5%
1.50%
-29.1%
Q1 2018$1,166,000
+62.8%
89,700
+124.2%
2.12%
+117.2%
Q4 2017$716,000
+42.6%
40,000
+100.0%
0.98%
+42.0%
Q3 2017$502,00020,0000.69%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders